Calidad de vida de los pacientes con porfiria hepática aguda con ataques recurrentes en España. Estudio COPHASE
XIV Congreso Nacional de la Sociedad Española de Errores Congénitos del Metabolismo. Santiago de Compostela. 15-17 dic 2021
A Multi-Stakeholder Multicriteria Decision Analysis for the Reimbursement of Orphan Drugs (FinMHU-MCDA study)
Orphanet J Rare Dis. 2021 Apr 26;16(1):186
A Multi-Stakeholder Multicriteria Decision Analysis in Rare Diseases: Reimbursement Criteria for Orphan Drugs in Spain (FinMHU-MCDA study)
23th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Virtual. 16-19 nov 2020
Análisis de decisión multicriterio multidecisor en enfermedades raras: criterios de financiación de medicamentos huérfanos en España (Estudio FinMHU-MCDA)
65 Congreso Nacional de la Sociedad Española de Farmacia Hospitalaria (SEFH). Virtual 20-22 oct 2020
Burden of disease in patients with fabry disease: Health related quality of life and associated factors
56th Congress of European Renal Association-European Dyalisis and Transplant Association (ERA-EDTA). Budapest (Hungary). Congress. 13-16 jun 2019
Burden of disease in patients with fabry disease: Economic burden of health care and non-health care resources consumption
56th Congress of European Renal Association-European Dyalisis and Transplant Association (ERA-EDTA). Budapest (Hungary). 13-16 jun 2019
Appl Health Econ Health Policy. 2010;8(5):301-15.